Despite advancements in treatments and deeper understanding of pathogenesis, the prognosis for<unk>  patients is poor , with early relapse and median survival time between 3–5 years.
B-cell prolymphocytic leukemia
Aggressive NK-cell leukemia
T-cell prolymphocytic leukemia
Precursor B-cell lymphoblastic leukemia
T-cell acute lymphoblastic leukemia
T-lymphoblastic leukemia/lymphoma
Acute myeloblastic leukemia with maturation
Acute myeloblastic leukemia without maturation